Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Radiographic and Clinical Outcomes Study Evaluating map3® Cellular Allogeneic Bone Graft in Patients Undergoing Bone Grafting in the Foot/Ankle

NCT02161016 is registered in ClinicalTrials.gov with RTI Surgical as lead sponsor.

NCT NCT02161016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02161016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Radiographic and Clinical Outcomes Study Evaluating map3® Cellular Allogeneic Bone Graft in Patients Undergoing Bone Grafting in the Foot/Ankle
Lead sponsor
RTI Surgical
Phase
Phase 4
Overall status
Terminated
Start date
June 30, 2014
Completion date
January 31, 2015
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deformity of bone, disorder of joint of foot, foot deformities, acquired, fracture of foot